Search - tctmd.com

Displaying 581 - 600 of 610

Sort: Relevancy | Date

News Daily News

El Tropismo Mejorado de las Células Madre Cardíacas contra la Cardiomiopatía resulta Prometedor

February 21, 2013

News Industry News

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

January 27, 2013

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

News Industry News

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

January 02, 2013

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Industry News

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

May 18, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

News Daily News

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

Yael L. Maxwell

March 08, 2012

News Daily News

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Yael L. Maxwell

March 08, 2012

News Daily News

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Caitlin E. Cox

March 06, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Industry News

Quality of life benefits of transcatheter aortic valve replacement differ by access site

November 09, 2011

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

News Conference News

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

November 09, 2011

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

Advertisement

El Tropismo Mejorado de las Células Madre Cardíacas contra la Cardiomiopatía resulta Prometedor

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

Small Heart Failure Studies Show Positive Trends for Cell Therapy

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Cell Therapy Trials Show Mixed Results at AHA 2012

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

Several Factors Behind False-Positive STEMI Activations

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Quality of life benefits of transcatheter aortic valve replacement differ by access site

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

New Stem Cell Therapies Promising in Severe Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content